Implementation of long-acting antiretrovirals shows promise for improving HIV/AIDS care in Africa, suggesting potential public health advancements.
Dear Editor, We write to bring to attention, a critical matter in public health and infectious diseases research - the advent, implementation, and utilization of Long-ActingAntiretroviralTherapy(LA-ART)injectables, specifically Cabotegravir–Rilpivirine (CAB/RPV), in the context of Africa and the developing regions of the world by extension.
No takes yet. Share an insight, caveat, or question.
Ashinze et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: